ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on Twitter

Kidney Week

Abstract: SA-PO622

Immunohistochemical Expression Pattern of RIP5, FGFR1, and FGFR2 in Normal Human Kidney Development and Congenital Anomalies of the Kidney and Urinary Tract (CAKUT)

Session Information

  • Pediatric Nephrology - II
    November 05, 2022 | Location: Exhibit Hall, Orange County Convention Center‚ West Building
    Abstract Time: 10:00 AM - 12:00 PM

Category: Pediatric Nephrology

  • 1800 Pediatric Nephrology

Authors

  • Vukojevic, Katarina, University of Split School of Medicine, Split, Splitsko-Dalmatinska županija, Croatia
  • Racetin, Anita, University of Split School of Medicine, Split, Splitsko-Dalmatinska županija, Croatia
  • Kelam, Nela, University of Split School of Medicine, Split, Splitsko-Dalmatinska županija, Croatia
  • Filipovic, Natalija, University of Split School of Medicine, Split, Splitsko-Dalmatinska županija, Croatia
  • Soljic, Violeta, University of Mostar School of Medicine, Mostar, Bosnia and Herzegovina
Background

RIP5 plays a key role in the urinary tract development, downstream of FGF-signaling and its impairment can lead to congenital anomalies of the kidney and urinary tract (CAKUT).

Methods

Human kidney tissues of 16 conceptuses between 22nd and 28th developmental weeks (dw) were used as a control, in the comparison with 21 CAKUT samples. Sections were stained with the double-immunofluorescence method with RIP5 and FGFR1/FGFR2 markers.

Results

RIP5 expression was higher in the collecting tubules (Ct) of CAKUT samples in comparison to control (p<0.0001), while in metanephric mesenchyme (mm) (3.5%) and glomeruli (g) (4.15%) was lower than in control (p<0.0001). The highest expression of FGFR1 and FGFR2 was observed in the collecting ducts (Cd) of both CAKUT cases and control. Additionally, expression of FGFR1 and FGFR2 was also higher in Ct and g of controls in comparison to CAKUT cases (p<0.0001).
RIP5 and FGFR1/FGFR2 co-expressed in Cd of controls, while RIP5 and FGFR1 did not co-express in CAKUT samples. In CAKUT cases RIP5 and FGFR2 co-expressed in mm and g.

Conclusion

Altered RIP5, FGFR1, and FGFR2 expression pattern in CAKUT cases in comparison to normal human kidney development might indicate its significance in FGF receptor signaling and normal kidney development.

a-d Immunofluorescence staining of developing human kidneys and CAKUT cases with RIP5, FGFR1, FGFR2 markers (arrows), and DAPI in different kidney structures (g–glomeruli, Ct–convoluted tubules, Cd–collecting duct, mm–metanephric mesenchyme) between 22nd and 28th developmental week. Merged pictures reveal co-expression of RIP5 and FGFR1 and RIP5 and FGFR2 in the collecting duct of controls (asterisks) and RIP5 and FGFR2 in the mm and g of CAKUT cases (asterisks). e-g Distribution of RIP5, FGFR and FGFR2 positive cells in the mm, g, Cd and Ct in human kidney development and CAKUT cases. Data were shown as mean ± SD, p<0.05 (two-way ANOVA with Sidak's multiple comparisons test).